Monte Buchsbaum
#86,178
Most Influential Person Now
American psychiatrist
Monte Buchsbaum's AcademicInfluence.com Rankings
Download Badge
Biology
Monte Buchsbaum's Degrees
- Doctorate Medicine Harvard University
- PhD Psychiatry Yale University
Why Is Monte Buchsbaum Influential?
(Suggest an Edit or Addition)According to Wikipedia, Monte Buchsbaum is a Professor emeritus of Psychiatry and Radiology at the University of California at San Diego. He was also the founder and editor in chief of Psychiatry Research and Psychiatry Research Neuroimaging from 1979 to 2019. He is the son of Invertebrate Biologist and author Ralph Buchsbaum.
Monte Buchsbaum's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- White matter changes in schizophrenia: evidence for myelin-related dysfunction. (2003) (778)
- Cortical glucose metabolic rate correlates of abstract reasoning and attention studied with positron emission tomography (1988) (647)
- Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. (1982) (515)
- Reduced prefrontal and increased subcortical brain functioning assessed using positron emission tomography in predatory and affective murderers. (1998) (511)
- Regional glucose metabolic changes after learning a complex visuospatial/motor task: a positron emission tomographic study (1992) (485)
- Brain abnormalities in murderers indicated by positron emission tomography (1997) (443)
- Sensation seeking and its biological correlates. (1980) (438)
- Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. (2000) (414)
- Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. (1980) (398)
- The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. (1976) (379)
- Selective reductions in prefrontal glucose metabolism in murderers (1994) (372)
- Intelligence and changes in regional cerebral glucose metabolic rate following learning (1992) (371)
- Positron emission tomographic measurements of pulvinar activity during an attention task (1990) (368)
- Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. (1978) (368)
- Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. (1986) (366)
- Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. (1984) (365)
- MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia (1998) (363)
- Platelet and plasma amine oxidase activity in 680 normals: Sex and age differences and stability over time (1976) (354)
- Striatal Volume on Magnetic Resonance Imaging and Repetitive Behaviors in Autism (2005) (351)
- Glucose Metabolic Rate in Normals and Schizophrenics During the Continuous Performance Test Assessed by Positron Emission Tomography (1990) (347)
- Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. (1999) (340)
- Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. (1992) (338)
- Stimulus Intensity Control and the Cortical Evoked Response (1968) (331)
- PET and MRI of the thalamus in never-medicated patients with schizophrenia. (1996) (318)
- Effect of sertraline on regional metabolic rate in patients with affective disorder (1997) (315)
- The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. (1990) (306)
- Naloxone alters pain perception and somatosensory evoked potentials in normal subjects (1977) (298)
- Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography. (1989) (289)
- Effect of sleep deprivation on brain metabolism of depressed patients. (1992) (280)
- d,l-fenfluramine Response in Impulsive Personality Disorder Assessed with [18F]fluorodeoxyglucose Positron Emission Tomography (1999) (274)
- Response inhibition in adolescents diagnosed with attention deficit hyperactivity disorder during childhood: an event-related FMRI study. (2004) (261)
- Regional and global changes in cerebral diffusion with normal aging. (2001) (244)
- Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. (2002) (229)
- The Interstitial Nuclei of the Human Anterior Hypothalamus: An Investigation of Variation with Sex, Sexual Orientation, and HIV Status (2001) (227)
- Feeling unreal: a PET study of depersonalization disorder. (2000) (226)
- Neural events and psychophysical law. (1971) (225)
- Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. (2008) (222)
- Individual differences in stimulus intensity response. (1971) (218)
- Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. (1993) (215)
- Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. (2002) (208)
- Ventricular Enlargement in Poor-Outcome Schizophrenia (1998) (203)
- Selected cases of poor outcome following a minor brain trauma: comparing neuropsychological and positron emission tomography assessment. (1994) (198)
- The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography. (1991) (198)
- Reduced Anterior and Posterior Cingulate Gray Matter in Borderline Personality Disorder (2005) (196)
- Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. (1997) (196)
- Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder. (2001) (195)
- The thalamus and schizophrenia: current status of research (2009) (195)
- Differential amygdala activation during emotional decision and recognition memory tasks using unpleasant words: an fMRI study (2001) (194)
- Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. (1999) (190)
- PET in generalized anxiety disorder (1991) (189)
- Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses (2005) (189)
- Biogenic amine-related enzymes and personality variations in normals (1977) (182)
- Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients (1987) (181)
- Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. (1992) (180)
- Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. (1998) (176)
- Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. (2006) (174)
- Positron Emission Tomography in Schizophrenic Patients with and without Neuroleptic Medication (1985) (173)
- Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder (2000) (172)
- PSYCHOLOGICAL CORRELATES OF MONOAMINE OXIDASE ACTIVITY IN NORMALS (1978) (170)
- Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. (1998) (163)
- Intrinsic Enjoyment and Boredom Coping scales: Validation with personality, evoked potential and attention measures. (1984) (159)
- Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression (2004) (158)
- Glucose utilization in the temporal cortex of affectively ill patients: Positron emission tomography (1987) (158)
- Topographic EEG changes with normal aging and SDAT. (1989) (156)
- Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients. (1998) (154)
- Laboratory Induced Aggression: A Positron Emission Tomography Study of Aggressive Individuals with Borderline Personality Disorder (2009) (153)
- Prefrontal glucose deficits in murderers lacking psychosocial deprivation. (1998) (147)
- Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. (1975) (144)
- A new system for gray-level surface distribution maps of electrical activity. (1982) (143)
- AER in affective disorders. (1971) (143)
- Frontal Lobe Metabolic Decreases with Sleep Deprivation not Totally Reversed by Recovery Sleep (2006) (143)
- Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task (2000) (141)
- Increased temporal lobe glucose use in chronic schizophrenic patients (1989) (140)
- Ventricular enlargement in schizophrenia related to volume reduction of the thalamus, striatum, and superior temporal cortex. (2004) (139)
- Average evoked response in bipolar and unipolar affective disorders: relationship to sex, age of onset, and monoamine oxidase. (1973) (138)
- Localized and lateralized cerebral glucose metabolism associated with eye movements during REM sleep and wakefulness: a positron emission tomography (PET) study. (1995) (137)
- Internal capsule, corpus callosum and long associative fibers in good and poor outcome schizophrenia: A diffusion tensor imaging survey (2007) (137)
- Cingulate gyrus volume and metabolism in the schizophrenia spectrum (2004) (137)
- Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study. (1996) (136)
- Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia (1996) (134)
- Biologic heterogeneity and psychiatrict research. Platelet MAO activity as a case study. (1979) (131)
- Self-Regulation of Stimulus Intensity: Augmenting/Reducing and the Average Evoked Response (1976) (131)
- Age and sex differences in averaged evoked responses in a normal population, with observations on patients with gonadal dysgenesis. (1974) (131)
- Volume of the cingulate and outcome in schizophrenia (2005) (130)
- Decreased anterior cingulate gyrus metabolic rate in schizophrenia. (1997) (130)
- Average evoked response and stimulus intensity in identical and fraternal twins (1974) (129)
- Effects of amphetamine on vigilance performance in normal and hyperactive children (1980) (127)
- D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia (2006) (126)
- Platelet Mao Activity and Evoked Potentials in the Identification of Subjects Biologically at Risk for Psychiatric Disorders (1979) (126)
- Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation (2006) (125)
- Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. (2003) (125)
- Average evoked responses in normal and minimally brain dysfunctioned children treated with amphetamine. (1973) (124)
- Deformation-Based Morphometry and Its Relation to Conventional Volumetry of Brain Lateral Ventricles in MRI (2001) (122)
- Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. (2004) (119)
- Ventricular volume and asymmetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging (1997) (119)
- Naloxone decreases diurnal variation in pain sensitivity and somatosensory evoked potentials. (1978) (118)
- Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients (2008) (117)
- Cortical intercorrelations of frontal area volumes in schizophrenia (2005) (116)
- Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder. (1987) (115)
- Analgesia to painful stimuli in affective illness. (1979) (114)
- MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes. (2003) (113)
- Suicide attempts, platelet monoamine oxidase and the average evoked response (1977) (109)
- Sleep deprivation as a model experimental antidepressant treatment: Findings from functional brain imaging (2001) (108)
- Alterations in cortisol negative feedback inhibition as examined using the ACTH response to cortisol administration in PTSD (2006) (107)
- Age-related shift in brain region activity during successful memory performance (1998) (105)
- Correlational methods for determining regional coupling of cerebral glucose metabolism: a pilot study. (1984) (105)
- Alternative Statistical Models for the Examination of Clinical Positron Emission Tomography/Fluorodeoxyglucose Data (1985) (104)
- Alterations in motor activity, sleep, and biochemistry in a cycling manic-depressive patient. (1977) (104)
- Functional and anatomical brain imaging: impact on schizophrenia research. (1987) (104)
- Hippocampal volume in aging combat veterans with and without post-traumatic stress disorder: relation to risk and resilience factors. (2007) (104)
- Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study. (2001) (103)
- Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder (2002) (103)
- Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone (1979) (101)
- Acute effects of caffeine in normal prepubertal boys. (1981) (100)
- Psychiatric vulnerability, monoamine oxidase, and the average evoked potential. (1980) (100)
- Caudate and putamen volumes in good and poor outcome patients with schizophrenia (2003) (99)
- Visual information and evoked responses from the left and right hemispheres. (1969) (98)
- A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia (2007) (98)
- Relative glucose metabolic rate higher in white matter in patients with schizophrenia. (2007) (98)
- The middle evoked response components and schizophrenia. (1977) (97)
- Cognitive processes in normal and hyperactive children and their response to amphetamine treatment. (1980) (96)
- Signal to noise ratio and response variability measurements in single trial evoked potentials. (1978) (91)
- Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls (1995) (90)
- Somatosensory evoked potentials during whole body hyperthermia in humans. (1981) (90)
- Opiate pharmacology and individual differences. II. Somatosensory evoked potentials (1981) (89)
- Olfactory memory in unmedicated schizophrenics (1993) (88)
- Frontal–striatal–thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating (2008) (87)
- Cardiovascular and neurophysiologic correlates of sensory intake and rejection. I. Effect of cognitive tasks. (1975) (87)
- Schizophrenia and stimulus intensity control. (1975) (87)
- Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia (2006) (86)
- Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder (1985) (86)
- Thalamic activation during an attention-to-prepulse startle modification paradigm: a functional MRI study (2001) (85)
- White matter fractional anisotropy and outcome in schizophrenia (2006) (84)
- Regional cerebral glucose metabolism and attention in adults with a history of childhood autism. (1992) (83)
- Lithium in children of lithium-responding parents (1981) (83)
- Diffusion Tensor Imaging in Schizophrenia (2006) (83)
- Behavioral and Cognitive Effects of Caffeine in Boys and Adult Males (1981) (82)
- Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia. (2001) (80)
- Impaired smooth pursuit eye movement: vulnerability marker for schizotypal personality disorder in a normal volunteer population. (1984) (80)
- Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients. (1985) (79)
- Measuring dopamine neuromodulation in the thalamus: Using [F-18]fallypride PET to study dopamine release during a spatial attention task (2006) (79)
- Effects of serotonin on memory impairments produced by ethanol. (1983) (78)
- Patterns of cortical activity in schizophrenia (1994) (78)
- Biological homogeneity, symptom heterogeneity, and the diagnosis of schizophrenia. (1978) (77)
- Lithium carbonate in the treatment of hyperactive children. (1973) (76)
- Structural and functional correlates of subsyndromes in chronic schizophrenia. (1995) (76)
- Frontal lobes, basal ganglia, temporal lobes--three sites for schizophrenia? (1990) (75)
- Urinary MHPG, stress response, personality factors and somatosensory evoked potentials in normal subjects and patients with major affective disorders. (1981) (75)
- Psychopathology: biological approaches. (1983) (74)
- Metabolic disconnection between the mediodorsal nucleus of the thalamus and cortical Brodmann's areas of the left hemisphere in schizophrenia. (2005) (74)
- Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Preliminary studies. (1991) (73)
- Hemispheric differences in evoked potentials to verbal and nonverbal stimuli in the left and right visual fields. (1970) (72)
- Positron emission tomographic image measurement in schizophrenia and affective disorders (1984) (72)
- Very poor outcome schizophrenia: Clinical and neuroimaging aspects (2007) (71)
- Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls (2007) (70)
- Thalamus size and outcome in schizophrenia (2004) (70)
- Opiate pharmacology and individual differences. I. Psychophysical pain measurements (1981) (70)
- A longitudinal study of the corpus callosum in chronic schizophrenia (2009) (70)
- Brief report: Attention performance in autism and regional brain metabolic rate assessed by positron emission tomography (1992) (69)
- Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus (2006) (68)
- Topographic cortical mapping of EEG sleep stages during daytime naps in normal subjects. (1982) (67)
- Temporal lobe volume determined by magnetic resonance imaging in schizotypal personality disorder and schizophrenia (2001) (67)
- Cerebral brain metabolism in adult dyslexic subjects assessed with positron emission tomography during performance of an auditory task. (1992) (65)
- EEG Alpha Rhythm and Glucose Metabolic Rate in the Thalamus in Schizophrenia (2001) (65)
- EEG coherence of prefrontal areas in normal and schizophrenic males during perceptual activation. (1991) (65)
- Batch-reactor microfluidic device: first human use of a microfluidically produced PET radiotracer. (2013) (64)
- Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia. (1992) (63)
- EVOKED RESPONSE AND KINESTHETIC MEASURES OF AUGMENTING/REDUCING IN SCHIZOPHRENICS: REPLICATIONS AND EXTENSIONS (1976) (63)
- Correlations between ventricular enlargement and gray and white matter volumes of cortex, thalamus, striatum, and internal capsule in schizophrenia (2011) (62)
- Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia (1989) (62)
- Positron emission tomography of the cerebellum in autism. (1989) (62)
- Brain size and cerebral glucose metabolic rate in nonspecific mental retardation and down syndrome (1995) (62)
- Sleep deprivation PET correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression. (2008) (61)
- The effects of attention, stimulus intensity, and individual differences on the average evoked response. (1973) (61)
- Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum (2007) (60)
- Enhancement of the average evoked response to tone onset and cessation. (1971) (60)
- ALTERED PAIN PERCEPTION AND CEREBROSPINAL ENDORPHINS IN PSYCHIATRIC ILLNESS (1982) (60)
- Magnetic resonance and positron emission tomography imaging of the corpus callosum: size, shape and metabolic rate in unipolar depression. (1993) (60)
- Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. (1996) (59)
- Comparative behavioral effects of clorgyline and pargyline in man: A preliminary evaluation (1979) (59)
- Clinical Neurochemical Implications of Sleep Deprivation's Effects on the Anterior Cingulate of Depressed Responders (2001) (59)
- Comparison of regional brain metabolism in bulimia nervosa and affective disorder assessed with positron emission tomography. (1990) (58)
- Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia. (2005) (58)
- Regional Glucose Metabolism within Cortical Brodmann Areas in Healthy Individuals and Autistic Patients (2004) (57)
- Abnormalities in hair trace elements as indicators of aberrant behavior. (1991) (57)
- Imaging monetary reward in pathological gamblers (2005) (57)
- Dimensional complexity of EEG waveforms in neuroleptic-free schizophrenic patients and normal control subjects. (1996) (57)
- Computer generation of surface distribution maps of measures of brain activity. (1982) (57)
- Enhanced Effects of Cortisol Administration on Episodic and Working Memory in Aging Veterans with PTSD (2007) (57)
- Reduced regional brain glucose metabolism assessed by positron emission tomography in electrodermal nonresponder schizophrenics: a pilot study. (1993) (57)
- Thalamocortical circuits: fMRI assessment of the pulvinar and medial dorsal nucleus in normal volunteers (2006) (56)
- Testing the Swerdlow/Koob model of schizophrena pathophysiology using positron emission tomography (1990) (56)
- Perceptual abnormalities in patients with chromatin negative gonadal dysgenesis and hypogonadotropic hypogonadism. (1980) (56)
- Regional cerebral blood flow during the wisconsin card sort test in schizotypal personality disorder (1997) (55)
- The Study of Personality with Positron Emission Tomography (1987) (55)
- Anterior and posterior cingulate cortex volume in healthy adults: Effects of aging and gender differences (2011) (54)
- Average evoked response augmenting/reducing in schizophrenia and affective disorders. (1975) (54)
- Augmenting and Reducing: Individual Differences in Evoked Potentials (1983) (54)
- Neuropsychological functioning in first-break, never-medicated adolescents with psychosis. (2004) (53)
- Research in endorphins and schizophrenia. (1979) (53)
- Correlations between MRI-assessed volumes of the thalamus and cortical Brodmann's areas in schizophrenia (2005) (53)
- Cortical intercorrelations of temporal area volumes in schizophrenia (2005) (52)
- Longitudinal Assessment of Gray and White Matter in Chronic Schizophrenia: A Combined Diffusion-Tensor and Structural Magnetic Resonance Imaging Study (2009) (52)
- Poor outcome in chronic schizophrenia is associated with progressive loss of volume of the putamen (2009) (52)
- Diffusion Tensor Anisotropy in Adolescents and Adults (2007) (51)
- Effects of cardiac and respiratory cycles on averaged visual evoked responses. (1965) (51)
- Positron Emission Tomography with Deoxyglucose-F18 Imaging of Sleep (2001) (50)
- Platelet monoamine oxidase, plasma dopamine-beta-hydroxylase and attention in a "biochemical high risk" sample. (1978) (49)
- Frontal cortex function. (2004) (49)
- Sex differences in perceptual differentiation and stimulus intensity control. (1973) (49)
- Physostigmine analgesia and somatosensory evoked responses in man N. Sitaram, M.S. Buchsbaum and C. Gillin, Europ. J. Pharmacol. 42 (1977) 285–290 (1977) (48)
- Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals (2018) (48)
- FDG-PET Study in Pathological Gamblers (2008) (48)
- Neuroleptic-induced hypothermia associated with amelioration of psychosis in schizophrenia. (1988) (48)
- A Dimensional Approach to the Autism Spectrum (1998) (48)
- Clozapine effects on glucose metabolic rate in striatum and frontal cortex. (1994) (47)
- Cardiovascular and neurophysiologic correlates of sensory intake and rejection. II. Interview behavior. (1975) (46)
- Statistical parametric mapping and cluster counting analysis of [18F] FDG-PET imaging in traumatic brain injury. (2010) (46)
- Greater Metabolic Rate Decreases in Hippocampal Formation and Proisocortex than in Neocortex in Alzheimer’s Disease (1997) (46)
- Simultaneous cerebral glucography with positron emission tomography and topographic electroencephalography. (1984) (45)
- Temporal lobe deficits in murderers: EEG findings undetected by PET. (2001) (45)
- In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis (2009) (45)
- Dextroamphetamine: cognitive and behavioral effects in normal and hyperactive boys and normal adult males. (1980) (45)
- Temporal characteristics of tract-specific anisotropy abnormalities in schizophrenia (2008) (44)
- Smooth pursuit eye tracking impairment: relation to other 'markers' of schizophrenia and psychologic correlates. (1982) (43)
- Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia (2018) (42)
- Monoamine oxidase type a in fibroblasts from patients with bipolar depressive illness (1980) (42)
- Abnormal EEG slow activity in left temporal areas in senile dementia of the Alzheimer type. (1990) (41)
- Patterns of cortical activity and memory performance in Alzheimer’s disease (2001) (41)
- Functional MRI of visuospatial working memory in schizotypal personality disorder: a region-of-interest analysis (2005) (41)
- Age and diffusion tensor anisotropy in adolescent and adult patients with schizophrenia (2009) (41)
- Smaller superior temporal gyrus volume specificity in schizotypal personality disorder (2009) (41)
- Computed EEG topography of response to visual and auditory stimuli. (1986) (41)
- Neuropsychological correlates of affective disorders. (1971) (41)
- FDG-PET in never-previously medicated psychotic adolescents treated with olanzapine or haloperidol (2007) (40)
- Functional brain imaging and aging in schizophrenia (1997) (40)
- Assessment of young men at risk for alcoholism with P300 from a visual discrimination task. (1988) (40)
- Sensorimotor gating deficits and hypofrontality in schizophrenia. (2001) (40)
- Changes in relative glucose metabolic rate following cortisol administration in aging veterans with posttraumatic stress disorder: an FDG-PET neuroimaging study. (2009) (39)
- PET and neurobehavioral evidence of tetrabromoethane encephalopathy. (1990) (39)
- Partial REM sleep deprivation, schizophrenia and field articulation. (1974) (39)
- FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia (2008) (39)
- Corpus callosum size and diffusion tensor anisotropy in adolescents and adults with schizophrenia (2015) (38)
- Parents of high risk subjects defined by levels of monoamine oxidase activity. (1980) (38)
- Topographic differences between normals and schizophrenics: the N120 evoked potential component. (1986) (37)
- EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease. (1995) (37)
- Hemispheric asymmetry for selective attention. (2000) (36)
- Greater left cerebral hemispheric metabolism in bulimia assessed by positron emission tomography. (1990) (36)
- EEG-averaged evoked response and perceptual variability in schizophrenics. (1970) (36)
- Correlations between volumes of the pulvinar, centromedian, and mediodorsal nuclei and cortical Brodmann's areas in schizophrenia (2006) (35)
- Investigation of abnormal left temporal functioning in dyslexia through rCBF, auditory evoked potentials, and positron emisson tomography (1991) (35)
- Neuropsychological functioning in first-break, never-medicated adolescents with psychosis (2003) (35)
- Auditory analgesia: somatosensory evoked response and subjective pain rating. (1976) (35)
- Diffusion tensor anisotropy in the cingulate gyrus in schizophrenia (2010) (34)
- Cerebral glucose metabolism in adults with early treated classic phenylketonuria. (2006) (34)
- Extreme MMPI scores and the Research Diagnostic Criteria. Screening college men for psychopathology. (1979) (34)
- Positron Emission Tomography Imaging of Risperidone Augmentation in Serotonin Reuptake Inhibitor-Refractory Patients (2006) (34)
- The Genain quadruplets: Electrophysiological, positron emission, and x-ray tomographic studies (1984) (34)
- Striatal size, glucose metabolic rate, and verbal learning in normal aging. (2003) (34)
- Internal capsule size in good-outcome and poor-outcome schizophrenia. (2006) (33)
- The cerebral neurobiology of hope and hopelessness. (1993) (33)
- Effects of Zolpidem on Local Cerebral Glucose Metabolism during Non-REM Sleep in Normal Volunteers: A Positron Emission Tomography Study (1996) (33)
- Deficient attentional modulation of the startle response in patients with schizotypal personality disorder. (2003) (33)
- Effects of sex and normal aging on regional brain activation during verbal memory performance (2010) (33)
- Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate (2002) (33)
- Positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia. (1991) (33)
- Effects of sensory input and alcohol adminstration on visual evoked potentials in normal subjects and alcoholics. (1980) (32)
- Pain enhances naloxone-induced hyperalgesia in humans as assessed by somatosensory evoked potentials (2004) (31)
- New methods to determine the CNS effects of antigeriatric compounds: EEG topography and glucose use (1982) (30)
- Brain imaging in the search for biological markers in affective disorder. (1986) (30)
- Diurnal variation in serum and urine electrolytes. (1971) (30)
- Brodmann area analysis of white matter anisotropy and age in schizophrenia (2011) (29)
- Effect of sleep stage and stimulus intensity on auditory average evoked responses. (1975) (29)
- An Adaptive-Rate Continuous Performance Test: Vigilance Characteristics and Reliability for 400 Male Students (1980) (29)
- Application of Somatosensory Event Related Potentials to Experimental Pain and the Pharmacology of Analgesia (1979) (29)
- Attention dysfunction and psychopathology in college men. (1985) (28)
- Ventricular enlargement associated with linkage marker for schizophrenia-related disorders in one pedigree. (1996) (28)
- Topographic mapping of EEG artifacts. (1987) (28)
- Psychological characteristics corresponding to low versus high platelet monoamine oxidase activity. (1979) (27)
- The effect of anxiety and hostility in silent mentation on localized cerebral glucose metabolism. (1992) (27)
- Serotonin transporter binding after recovery from bulimia nervosa. (2012) (27)
- Gender comparisons of cerebral glucose metabolic rate in healthy adults during a cognitive task (1996) (27)
- A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in man. (1979) (27)
- Use of narcotic antagonists to study the role of endorphins in normal and psychiatric patients (1979) (26)
- Naloxone effects on β-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers (2004) (26)
- 18F-Fallypride binding potential in patients with schizophrenia compared to healthy controls (2010) (26)
- Basal Ganglia Activity in Pathological Gambling: A Fluorodeoxyglucose-Positron Emission Tomography Study (2010) (26)
- Diametrical relationship between gray and white matter volumes in autism spectrum disorder and schizophrenia (2017) (26)
- Zimelidine effects on memory impairments produced by ethanol. (1983) (25)
- Average evoked responses in a rapidly cycling manic-depressive patient. (1977) (25)
- Pain sensitivity and endorphins in functional psychoses. (1981) (25)
- Normal pain sensitivity in patients with panic disorder (1985) (25)
- Evoked potential studies of brain catecholamine alterations in monkeys. (1975) (24)
- The relationship of plasma free MHPG to anxiety and psycho-physical pain in normal volunteers. (1982) (24)
- Neuroimaging Bipolar Illness With Positron Emission Tomography and Magnetic Resonance Imaging (1997) (24)
- EEG topography of response to visual stimuli in generalized anxiety disorder. (1987) (24)
- Neuroimaging studies in post-traumatic stress disorder. (2002) (24)
- Psychological characteristics of subjects identified by platelet MAO activity and evoked potentials as biologically at risk for psychopathology. (1980) (24)
- Positron-emission tomographic studies of the relationship of cerebral glucose metabolism and the magnitude of anxiety and hostility experienced during dreaming and waking. (1991) (24)
- Cerebral metabolic consequences of electrical cutaneous stimulation in normal individuals. (1983) (24)
- Regional cerebral blood flow changes in drug-resistant depressed patients following treatment with transcranial magnetic stimulation: a statistical parametric mapping analysis. (2002) (24)
- Changes in relative glucose metabolic rate following cortisol administration in aging veterans with posttraumatic stress disorder: An FDG-PET neuroimaging study (2009) (23)
- 2-year follow-up of subjects and their families defined as at risk for psychopathology on the basis of platelet MAO activities. 2-year follow-up of low platelet MAO. (1982) (23)
- Anterior limb of the internal capsule in schizotypal personality disorder: Fiber-tract counting, volume, and anisotropy (2012) (23)
- Effects of amitriptyline, desipramine and zimeldine, alone and in combination with ethanol, on information processing and memory in healthy volunteers (1983) (23)
- Adolescent developmental change in topography of EEG amplitude (1992) (23)
- Psychophysical Pain Judgments and Somatosensory Evoked Potentials in Patients with Affective Illness and in Normal Adults (1980) (22)
- Language in dreaming and regional EEG alpha power. (1996) (22)
- Gamma-hydroxybutyrate treatment of schizophrenia: a pilot study. (1981) (21)
- The effect of doxapram on brain imaging in patients with panic disorder (2007) (20)
- Increased white matter metabolic rates in autism spectrum disorder and schizophrenia (2018) (20)
- Paranoia and platelet MAO in normals and nonschizophrenic psychiatric groups. (1979) (20)
- AUDITORY ANALGESIA: SOMATOSENSORY EVOKED RESPONSE AND SUBJECTIVE PAIN RATING (1978) (19)
- Genetic Factors in EEG, Sleep, and Evoked Potentials (1980) (19)
- Use of a small process control computer in a psychophysiological laboratory. (1971) (19)
- The Genain quadruplets: Psychological studies (1984) (19)
- Human somatosensory evoked responses: Effects of attention and distraction on early components (1980) (19)
- Progressive Ventricular Expansion in Chronic Poor-outcome Schizophrenia (2010) (19)
- Tacrolimus-associated mutism after orthotopic liver transplantation. (2000) (19)
- The effects of sleep deprivation on average evoked responses in depressed patients and in normals. (1981) (19)
- Hypofrontality in schizophrenia as assessed by PET. (1987) (18)
- Anxiety levels in dreams: relation to localized cerebral glucose metabolic rate (1991) (18)
- The Genain quadruplets 25 years later: A diagnostic and biochemical followup (1984) (18)
- Schizophrenia and platelet monoamine oxidase: research strategies. (1980) (17)
- 16 – Geometric and Scaling Issues in Topographic Electroencephalography (1986) (17)
- Effect of Opiates and Opiate Antagonists on Somatosensory Evoked Potentials in Patients with Schizophrenia and Normal Adults (1980) (16)
- Metabolic thalamocortical correlations during a verbal learning task and their comparison with correlations among regional volumes (2006) (16)
- Effects of antidepressants on skilled performance. (1984) (16)
- Focal left temporal slow EEG activity is related to a verbal recent memory deficit in a non-demented elderly population. (1991) (16)
- Alterations of evoked potentials link research in attention dysfunction to peptide response symptoms of schizophrenia. (1980) (16)
- Explorations in the relationship of dream sleep to schizophrenia using positron emission tomography. (1990) (16)
- A new iterative reconstruction technique for attenuation correction in high-resolution positron emission tomography (1996) (16)
- Differential effects of "congruence," stimulus meaning, and information of early and late components of the average evoked response. (1974) (16)
- Effects of amoxapine and imipramine on evoked potentials in the Continuous Performance Test in patients with affective disorder. (1988) (15)
- Multimodal canonical correlation reveals converging neural circuitry across trauma-related disorders of affect and cognition (2018) (15)
- Intravenous l‐DOPA Plus Carbidopa in Depressed Patients: Average Evoked Response, Learning, and Behavioral Changes (1976) (15)
- Visual Evoked Potential Topography in Patients with Schizophrenia and Normal Controls (1982) (14)
- PLATELET MONOAMINE OXIDASE AS A BIOLOGICAL MARKER IN THE AFFECTIVE DISORDERS AND ALCOHOLISM (1982) (14)
- Signal-to-noise Ratio and Response Variability in Affective Disorders and Schizophrenia (1979) (14)
- Gender differences in cortical glucose metabolism in Alzheimer's disease and normal aging. (1996) (14)
- Biological vulnerability to depression: replication of MAO and evoked potentials as risk factors. (1988) (14)
- Clusters of Low (18)F-Fluorodeoxyglucose Uptake Voxels in Combat Veterans with Traumatic Brain Injury and Post-Traumatic Stress Disorder. (2015) (13)
- A new approach to very high resolution mini-brain PET using a small number of large detectors (1990) (13)
- Regional Correlations in Patterns of Glucose Use in Patients with Schizophrenia and Normal Subjects During Mild Pain Stimulation (1983) (13)
- Unilateral temporal lobectomy and changes in evoked responses during recognition of verbal and nonverbal material in the left and right visual fields. (1971) (13)
- Positron emission tomography studies of abnormal glucose metabolism in schizophrenic illness. (1995) (13)
- Psychophysiology and schizophrenia. (1977) (13)
- D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia (2017) (13)
- Positive association between cerebral grey matter metabolism and dopamine D2/D3 receptor availability in healthy and schizophrenia subjects: An 18F-fluorodeoxyglucose and 18F-fallypride positron emission tomography study (2020) (13)
- Contrast effects on the auditory evoked response and its relation to psychophysical judgments (1971) (13)
- Unusual visual symptoms and Ganser-like state due to cerebral injury: a case study using (18)F-deoxyglucose positron emission tomography. (1998) (12)
- A method of basal forebrain anatomical standardization for functional image analysis (1998) (12)
- Platelet monoamine oxidase activity and life stress as predictors of psychopathology and coping in a community sample (1989) (12)
- Selective attention, inhibition for repeated events and hemispheric specialization (2003) (11)
- Handbook of Biological Psychiatry, Part II: Brain Mechanisms and Abnormal Behavior—Psychophysiology (1981) (11)
- Exploring the Relationship between Having Control and Losing Control to Functional Neuroanatomy within the Sleeping State (1995) (11)
- fMRI assessment of thalamocortical connectivity during attentional performance. (2013) (10)
- Charting the circuits (1995) (9)
- Alcohol induced changes in regional cerebral glucose metabolic rate during divided attention (1999) (9)
- Apomorphine, haloperidol and the average evoked potentials in normal human volunteers. (1980) (9)
- An 18-month followup of students biologically at risk for psychiatric problems. (1980) (9)
- Neural correlates of malingering in mild traumatic brain injury: A positron emission tomography study (2015) (9)
- Evoked Potential Measures of Attention and Psychopathology (1981) (9)
- Preparation and preliminary biological evaluation of [18F]NCQ-115: a new selective reversible dopamine D2 receptor ligand. (1993) (9)
- Functional brain imaging, sleep, and sleep deprivation: contributions to the “overarousal” hypothesis of depression (1995) (8)
- Serum calcium concentration and the average evoked response. (1971) (8)
- Childhood obsessive-compulsive disorder. (1981) (8)
- Relationships between platelet and plasma monoamine oxidase, plasma dopamine-beta-hydroxylase, and urinary 3-methoxy-4-hydroxy phenylglycol. (1975) (8)
- Data acquisition system for precision eye-fixation studies (1973) (8)
- Auditory analgesia: somatosensory evoked response and subjective pain rating R. Lavine, M.S. Buchsbaum and M. Poncy, Psychophysiology, 13 (1976) 140–148 (1977) (8)
- Three Dimensional PET/MRI Images in OCD and Schizophrenia (1997) (8)
- Dopamine receptor density and white mater integrity: 18F-fallypride positron emission tomography and diffusion tensor imaging study in healthy and schizophrenia subjects (2018) (8)
- Handedness and cortical hemisphere effects in sine wave stimulated evoked responses. (1971) (8)
- Effects of carbohydrate-active steroids and ACTH on visually-evoked responses in patients with adrenal cortical insufficiency. (1975) (7)
- PSYCHOLOGICAL AND PHYSIOLOGICAL CORRELATES OF VARIATIONS IN SMOOTH PURSUIT EYE MOVEMENTS (1982) (7)
- ROLE OF OPIOID PEPTIDES IN DISORDERS OF ATTENTION IN PSYCHPATHOLOGY (1982) (7)
- Neuropsychological Characteristics of College Males Who Show Attention Dysfunction (1983) (7)
- Chapter 5 – Computer Use in Bioelectric Data Collection and Analysis (1974) (7)
- Functional Indices of Biological Disturbance (1983) (7)
- Positron emission tomography study of phencyclidine users (1991) (7)
- Individual differences in average evoked responses to d- and l-amphetamine with and without lithium carbonate in depressed patients (1977) (7)
- Visual target detection paradigm for the study of selective attention. (2000) (7)
- A FDG-PET and fMRI Study on Glucose Metabolism and Hemodynamic Response during Visual Attentional Performance in Schizophrenia (2013) (7)
- Glucose metabolic rate and progression of illness in Alzheimer's disease (1995) (6)
- Progress in Mind: Focus on Alcohol Use Disorders, an Elsevier Resource Centre (2015) (6)
- Platelet monoamine oxidase activity and human sleep. (1978) (5)
- Commentary on "The current status of PET scanning with respect to schizophrenia". (1992) (5)
- Augmentation/reduction update (1986) (5)
- Evidence, Evidence-Based Medicine, and Evidence Utility in Psychiatry and Electrophysiology (2009) (5)
- The relationship of plasma-free MHPG to anxiety in psychophysical pain in normal volunteers Psychopharmacol. Bull., 18 (1982) 129–131 (1984) (5)
- Flurbiprofen, caffeine and analgesia: Interaction with introversion/extraversion (1991) (5)
- Average evoked response and muscle tension (1973) (5)
- PET STUDIES OF DRUG INTERACTION WITH BRAIN REGIONAL GLUCOSE METABOLISM (1992) (5)
- The Cerebral Neurobiology of Anxiety, Anxiety Displacement, and Anxiety Denial (2001) (5)
- Attention Performance in Autism and Regional Brain Metabolic Rate Assessed by Positron Emission Tomography. Brief Report. (1992) (4)
- Cholinergic Modulation of Sleep, Growth Hormone and Analgesia in Normal Volunteers (1978) (4)
- CLONIDINE AND PSYCHOPHYSICAL PAIN (1980) (4)
- Average Evoked Response: Techniques and Applications (1970) (4)
- Physiological responses of men alcoholics and controls to varying sensory stimulation. (1979) (4)
- An automatic MR-PET registration algorithm (1996) (4)
- 395. Cortical and subcortical volumes in patients with schizotypal personality disorder (2000) (3)
- Neural differences underlying face processing in veterans with TBI and co-occurring TBI and PTSD. (2017) (3)
- 458 Positron emission tomography in schizophrenics treated with atypical and typical neuroleptics (1997) (3)
- PHENYLETHYLAMINE (PEA) AND CHRONIC SCHIZOPHRENIA (1979) (3)
- ROLE OF OPIOID PEPTIDES IN DISORDERS OF ATTENTION IN PSYCHOPATHOLOGY (1982) (3)
- ROLE OF OPIOID PEPTIDES IN DISORDERS OF ATTENTION IN PSYCHOPATHOLOGY (1982) (3)
- Neuroimaging and the aging process in psychiatry (1994) (3)
- Functional Brain Imaging Studies in Dementia (2011) (3)
- Neuroimaging, VII: PET and the averaging of brain images. (1996) (3)
- ERL—A language for implementing evoked response and psychophysiological experiments (1971) (3)
- Relation of deformation- and voxel-based morphometry to conventional volumetry of brain lateral ventricles in MRI (2001) (3)
- 112. Temporal lobe volume in schizotypal personality disorder and schizophrenia (2000) (3)
- PET studies of hippocampal metabolism in patients with Alzheimer's disease during an olfactory memory task (1989) (3)
- Update on PET glucose neuroimaging (1997) (3)
- The relationship between social alienation and disorganized thinking in normal subjects and localized cerebral glucose metabolic rates assessed by positron emission tomography. (1992) (3)
- 322. Diffusion tensor imaging in schizophrenia and schizophrenia spectrum disorders (2000) (3)
- 3.29 – Alzheimer’s Disease: Neurostructures (2008) (2)
- Relationship between white matter glucose metabolism and fractional anisotropy in healthy and schizophrenia subjects (2020) (2)
- Biological high-risk paradigm and platelet MAO activity in community samples. (1983) (2)
- P.3.023 Positron emission tomography in schizophrenic patients treated with sertindole and haloperidol (1996) (2)
- Specificity of position emission tomographic findings in schizophrenia (1989) (2)
- Comparison between Voxel-based Morphometry and Volumetric Analysis in Schizophrenia (2008) (2)
- A Role for Opioid Peptides in Attentional Functioning Clinical Implications (1982) (2)
- PLATELET MONOAMINE OXIDASE AND CORTICAL EVOKED POTENTIALS AS PREDICTORS OF PSYCHIATRIC VULNERABILITY (1979) (2)
- Neurocognitive profile of adolescents with early-onset schizophrenia and their unaffected siblings (2022) (2)
- Schizophrenia. Charting the circuits. (1995) (2)
- AUTONOMIC AFFERENT INFLUENCE ON VOLUNTARY BEHAVIOR (1964) (2)
- Schizophrenia and Bipolar illness: can imaging answer the dichotomy or spectrum question? (2008) (2)
- PRESENTATION OF MULTILEAD EEG BY TOPOGRAPHIC MAPS OF ELECTRICAL ACTIVITY (1981) (2)
- Reading abilities and dopamine D2/D3 receptor availability: An inverted U-shaped association in subjects with schizophrenia (2021) (2)
- Structural brain differences between poor outcome and good outcome patients with schizophrenia (2003) (2)
- Neural Correlates of Autobiographical Memory: Evidence From a Positron Emission Tomography Study in Patients With Mild Cognitive Impairment and Alzheimer's Disease (2021) (1)
- Clozapine markedly affects glucose metabolic rate in the striatum and cortex (1993) (1)
- 223. Functional imaging and neuropsychological tasks in schizophrenia and dementia research (1998) (1)
- Simultaneous Electroencephalographic and Cerebral Metabolic Rate Measurement (1993) (1)
- Similarity of effects of alcohol and sensory stimulation in post-alcoholics and controls. (1979) (1)
- Biochemistry — “High Risk” Predictor (1977) (1)
- ALPHA RHYTHM AND CORTICAL AND SUBCORTICAL METABOLISM ‐ A COMBINED PET AND EEG STUDY IN NORMAL CONTROLS AND SCHIZOPHRENIC PATIENTS. (1992) (1)
- The anterior cingulate glucose metabolic rate in schizophrenia (1995) (1)
- Neuropsychological functioning and subcortical glucose metabolism in normal weight bulimics (1989) (1)
- 65-140 Positron emission tomography in schizophrenics treated with atypical and typical neuroleptics (1997) (1)
- Forty years of editorship of psychiatry research (2019) (1)
- Frontal and striatal volumes in schizotypal personality disorder and schizoprenia assessed with MRI: Neuropsychological and phenomenological correlates (1995) (1)
- Editors' progress report (1979) (1)
- A Manual, Semi-Automated and Automated ROI Study of fMRI Hemodynamic Response in the Caudate Nucleus (2013) (1)
- A study of cerebral glucose metabolism and hemodynamic response in schizophrenia (2011) (1)
- 22. Serotonergic responsiveness in impulsive/aggressive personality disorders (2000) (1)
- Screening young adults for psychiatric vulnerability: a preliminary comparison of biological and clinical measures. (1979) (1)
- Neuropsychological Vulnerability to Schizophrenia (2019) (1)
- THE RELATIONSHIP OF PLATELET MAO ACTIVITY TO PSYCHOLOGICAL VARIABLES UNDERLYING PSYCHIATRIC DIAGNOSES (1982) (1)
- Neuropsychological, EEG and pet scan effects of thalamic stimulation in humans: A model for schizophrenia (1993) (1)
- Alcoholics and high-low sensory input: a pilot study. (1977) (1)
- Prefrontal Dysfunction in Murderers Lacking Psychosocial Deficits (1997) (1)
- Extraction of physiologic signals with independent component analysis (ICA) (2010) (1)
- Average evoked responses and psychophysical performance in patients with pseudohypoparathyroidism (1972) (1)
- Cognitive changes and the averaged evoked response in depression (1979) (1)
- Advances in the Use of Visual Imaging: Techniques in Mental Illness (1983) (1)
- Striatal-thalamic disorder of cerebral metabolism in never-medicated schizophrenics (1991) (1)
- 349. A pet study of bulimia nervosa reveals caudate hypermetabolism (1996) (1)
- White matter in schizophrenia: larger in volume, more disorganized, and more metabolically active (2006) (1)
- 283. D2/D3 Dopamine Receptor Binding with [F-18] Fallypride Correlates of Executive Function in Medication-Naïve Patients with Schizophrenia (2017) (1)
- Functional imaging with spect of cognitive activity in schizotypals (1994) (1)
- The editors respond (1983) (1)
- Four-modality imaging of unmedicated subjects with schizophrenia: 18F-fluorodeoxyglucose and 18F-fallypride PET, diffusion tensor imaging, and MRI (2021) (1)
- MAGNETIC RESONANCE AND DIFFUSION TENSOR IMAGING STUDY OF THE CORPUS CALLOSUM IN ADOLESCENT AND ADULT SCHIZOPHRENIA (2008) (0)
- Editorial (1983) (0)
- Subject Index Vol. 43, 2001 (2001) (0)
- 301. Quantitative MRI in bipolar and schizophrenic patients (2000) (0)
- Altered metabolism of cortical brodmann areas in schizophrenia during a verbal learning task (2000) (0)
- Bold FMRI activation in schizotypal personality disorder patients during a visuospatial working memory task (2003) (0)
- Subject Index Vol. 31, 1995 (1995) (0)
- Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia (2017) (0)
- Cortical glucose metabolism in male schizophrenic patients and controls matched for CPT performance (1996) (0)
- The effects of recorded fighting sounds on the latency to fight in mice. (1959) (0)
- THE BIOLOGICAL RISK STRATEGY. BIOLOGICAL MARKERS: PERSONALITY MODULATORS OR DIAGNOSTIC TESTS? (1984) (0)
- Contents Vol. 43, 2001 (2001) (0)
- Regional glucose metabolism assessed by PET as a tool for studying clinical response to typical & atypical neuroleptics (1991) (0)
- Cerebral correlates of autobiographical memory in MCI and AD: Evidence from a positron‐emission tomography study (2020) (0)
- 343. Three-dimensional visualization of the fronto-striato-thalamic circuitry in schizophrenia (1996) (0)
- 8. Risk and protective factors across the schizophrenia spectrum (1996) (0)
- The Editor-in-Chief and Editors of Pain wish to thank the following consultants and referees for making available their expert knowledge in reviews of manuscripts (1983) (0)
- FDG-PET AND DIFFUSION TENSOR IMAGING OF THALAMOCORTICAL AND WHITE MATTER CORRELATIONS (2008) (0)
- Magnetic Resonance and Positron Emission Tomography Imaging of the Temporal Lobe in Schizophrenia (1994) (0)
- Gender differences in cortical metabolism in schizophrenia (1995) (0)
- P.1.e.019 Size, FDG-PET activity, and neuroleptic responsivity of the medialdorsal nucleus of the thalamus in schizophrenia (2007) (0)
- Diametrical relationship between gray and white matter volumes in autism spectrum disorder and schizophrenia (2016) (0)
- Brain imaging of sleep (1998) (0)
- 79. D2/D3 Dopamine Receptor Binding With [F-18] Fallypride Correlates of Executive Function in Medication-Naive Patients With Schizophrenia. (2017) (0)
- 356. Prefrontal-thalamic network for sensory gating in normal individuals (1996) (0)
- PROGRESSION OF WHITE MATTER PATHOLOGY IN CHRONIC SCHIZOPHRENIA: A COMBINED DIFFUSION-TENSOR AND STRUCTURAL MAGNETIC RESONANCE IMAGING STUDY (2008) (0)
- Positron Emission Transaxial Tomography (1985) (0)
- 344. Brain GMR in schizophrenics and controls matched for CPT score (1996) (0)
- Subject Index Vol. 19, 1975 (1975) (0)
- Naloxone alters pain perception and somatosensory evoked potentials in normal subjects M.S. Buchsbaum, G.C. Davis and W.E. Bunney, Nature (Lond.), 270 (1977) 620–622 (1979) (0)
- 21. BULIMIA NERVOSA: A DISTURBANCE OF SEROTONIN/ORBITAL FRONTAL CORTEX MODULATION? (2000) (0)
- ELECTROPHYSIOLOGICAL CORRELATES OF COGNITIVE DYSFUNCTIONS IN PSYCHIATRIC PATIENTS, INCLUDING SENILE DEMENTIA (1981) (0)
- P-17-1 Positron emission tomography in schizophrenics treated with sertindole and haloperidol (1996) (0)
- SIR: The report "Comparison of PET Measurement of Local Brain Glucose Metabolism and CAT Measurement of (1987) (0)
- 23-7: Diffusion tensor analysis of white matter pathways in schizophrenia (1997) (0)
- Decreased hippocampal metabolic rate in patients with SDAT assessed by positron emission tomography during olfactory memory task (1990) (0)
- P.3.c.004 White matter volume and anisotropy in never medicated psychotic adolescents treated with olanzapine and haloperidol (2007) (0)
- Positron emissions tomography and magnetic resonance imaging of the striatum in schizophrenia (1995) (0)
- Brain imaging. (1982) (0)
- WHITE MATTER VOLUME IN THE SCHIZOPHRENIA SPECTRUM (2008) (0)
- Computer Assisted Assessment of Analgesia During General Anesthesia (1980) (0)
- Glucose metabolic rate of the basal ganglia in schizophrenia (1995) (0)
- Prediction of clinical response to neuroleptics and positron emission tomography in schizophrenia (1994) (0)
- S.18.01 Schizophrenia: Effects of aging on cognition (2003) (0)
- Global and local attentional processing following optic neuritis (2010) (0)
- 03 - Association of verbal fluency and reading impairments with dopamine D2/D3 receptor density in schizophrenia: an 18F-fallypride positron emission tomography study. (2019) (0)
- Medial and lateral frontal cortex metabolic change in schizophrenia (1993) (0)
- Fluorodeoxyglucose positron emission tomography scans in patients with alcohol use disorder scans in patients with alcohol use disorder. (2022) (0)
- Dr. Wu and Colleagues Reply (2000) (0)
- Metabolic changes with age in schizophrenia (1997) (0)
- S-37-3 Neurobiologyy of the schizophrenia spectrum (1996) (0)
- THIS MONTH IN ARCHIVES OF GENERAL PSYCHIATRY This Month in Archives of General Psychiatry PERSPECTIVES (2005) (0)
- Brain imaging techniques for diagnosis and drugs against schizophrenia (1986) (0)
- Prefrontal activation during the WCST in schizotypal personality (1995) (0)
- Increased white matter metabolic rates in autism spectrum disorder and schizophrenia (2017) (0)
- [Long latency auditory evoked potentials: value of multichannel analysis and of high-resolution graphic mapping]. (1987) (0)
- WITHDRAWN: Forty years of Editorship of Psychiatry Research (2019) (0)
- G changes with normal aging and S D A (2002) (0)
- Secondary Schizophrenia: Functional neuroimaging in schizophrenia (2010) (0)
- Positron Emission Tomography and Computed Tomography Measurement of Brown Fat Thermal Activation: Key Tool for Developing Novel Pharmacotherapeutics for Obesity and Diabetes (2019) (0)
- Average evoked responsesandpsychophysical performance inpatients with pseudohypoparathyroidism (1972) (0)
- Neuroimaging correlates of genetic marker for schizophrenia (1995) (0)
- P.3.a.010 Continued loss of gray matter in chronic treatment-resistant schizophrenia (2008) (0)
- Frontal and temporal cortex function in schizophrenia during a memory task (1995) (0)
- Metabolic imaging with positron emission tomography in schizophrenia (1994) (0)
- CAUDATE AND PUTAMEN VOLUME IN UNMEDICATED SCHIZOPHRENIA-SPECTRUM PATIENTS (2008) (0)
- [Not Available]. (2009) (0)
- 73. Fronto-striatal circuits assessed by positron emission tomography in patients treated with atypical neuroleptics, typical neuroleptics, and fenfluramine (1998) (0)
- New Research Techniques for Studying the Functional Anatomy of Depression (1983) (0)
- Positron-Emission Tomography and Computed Tomography Measurement of Brown Fat Thermal Activation: Key Tools for Developing Novel Pharmacotherapeutics for Obesity and Diabetes (2015) (0)
- Gender Differences In Regional Brain Glucose Metabolism In Alzheimer'S Disease And Normal Aging (1994) (0)
- P.1.e.002 Longitudinal assessment of white matter in schizophrenia: a combined diffusion-tensor and structural MR imaging study (2007) (0)
- 543. Lateral and medial temporal Lobe metabolic rate in Alzheimer's disease (1996) (0)
- Magnetic Resonance and Positron Emission Tomography Imaging of the Basal Ganglia in Schizophrenia (1994) (0)
- aboratory Induced Aggression : A Positron Emission omography Study of Aggressive Individuals with orderline Personality Disorder (2013) (0)
- Delayed word recall in aged schizophrenia (1994) (0)
- Metabolic rates in Brodmann areas of Alzheimer's patients (1995) (0)
- A neuroimaging correlate for a schizophrenia-related genetic marker in one pedigree (1995) (0)
- Potentiels evoques auditifs a longue latence : Interets de l'analyse multivoie et de la representation cartographique haute resolution (1987) (0)
- educed Anterior and Posterior Cingulate Gray Matter n Borderline Personality Disorder (2005) (0)
- Amygdala and occipital activation during the explicit processing of unpleasant and neutral words (2001) (0)
- Biological heterogeneity in schizophrenic patients. (1979) (0)
- LOCALIZED GLUCOSE METABOLISM ASSESSED BY POSITRON EMISSION TOMOGRAPHY DURING SLEEP AND SLEEP DEPRIVATION (1992) (0)
- Magnetic Resonance and Positron Emission Tomography Imaging of the Cerebellum in Schizophrenia (1994) (0)
- Pen changing as psychological stress in obese and normal shetland sheep dogs. (1959) (0)
- ANISOTROPY AND TRACTOGRAPHY IN THE INTERNAL CAPSULE IN THE SCHIZOPHRENIA SPECTRUM (2008) (0)
- Naloxone decreases diurnal variation in pain sensitivity and somatosensory evoked potentials G.C. Davis, M.S. Buchsbaum and W.E. Bunney, Jr., Life Sci., 23 (1978) 1449–1460 (1979) (0)
- P.3.c.033 FDG-PET and MRI imaging of the effects of sertindole in the striatum in schizophrenia (2006) (0)
- Dopamine receptor density and white mater integrity: 18F-fallypride positron emission tomography and diffusion tensor imaging study in healthy and schizophrenia subjects (2018) (0)
- A Manual, Semi-Automated and Automated ROI Study of fMRI Hemodynamic Response (2013) (0)
This paper list is powered by the following services:
Other Resources About Monte Buchsbaum
What Schools Are Affiliated With Monte Buchsbaum?
Monte Buchsbaum is affiliated with the following schools:
